| Year |
Citation |
Score |
| 2020 |
Gurler D, White DM, Kraguljac NV, Ver Hoef L, Martin C, Tennant B, Lahti AC. Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment. Neuropsychobiology. 1-13. PMID 32316023 DOI: 10.1159/000506402 |
0.357 |
|
| 2015 |
Gurler D, Doyle N, Walker E, Magnotti J, Beauchamp M. A link between individual differences in multisensory speech perception and eye movements. Attention, Perception & Psychophysics. 77: 1333-41. PMID 25810157 DOI: 10.3758/S13414-014-0821-1 |
0.314 |
|
| 2015 |
Bag AK, Kim H, Gao Y, Bolding M, Warren PP, Fathallah-Shaykh HM, Gurler D, Markert JM, Fiveash J, Beasley TM, Khawaja A, Friedman GK, Chapman PR, Nabors LB, Han X. Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. Journal of Neuro-Oncology. 122: 585-93. PMID 25711673 DOI: 10.1007/S11060-015-1751-Z |
0.548 |
|
| 2014 |
Bolding MS, Lahti AC, White D, Moore C, Gurler D, Gawne TJ, Gamlin PD. Vergence eye movements in patients with schizophrenia. Vision Research. 102: 64-70. PMID 25088242 DOI: 10.1016/J.Visres.2014.07.008 |
0.542 |
|
| 2014 |
Macher T, Totenhagen J, Sherwood J, Qin Y, Gurler D, Bolding MS, Bao Y. Ultrathin iron oxide nanowhiskers as positive contrast agents for magnetic resonance imaging Advanced Functional Materials. 25: 490-494. DOI: 10.1002/Adfm.201403436 |
0.502 |
|
| 2012 |
Bolding MS, Lahti AC, Gawne TJ, Hopkins KB, Gurler D, Gamlin PD. Ocular convergence deficits in schizophrenia. Frontiers in Psychiatry. 3: 86. PMID 23087652 DOI: 10.3389/Fpsyt.2012.00086 |
0.544 |
|
| Show low-probability matches. |